Existing anti-parasitic drug could offer treatment for Ebola

Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection. In meticulous experiments in human cells, the drug significantly amplified immune responses to Ebola and inhibited Ebola replication.